SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-018820
Filing Date
2023-05-08
Accepted
2023-05-08 16:14:23
Documents
72
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q atra-20230331.htm   iXBRL 10-Q 2867403
2 EX-10.1 atra-ex10_1.htm EX-10 56133
3 EX-31.1 atra-ex31_1.htm EX-31 17781
4 EX-31.2 atra-ex31_2.htm EX-31 17649
5 EX-32.1 atra-ex32_1.htm EX-32 13224
  Complete submission text file 0000950170-23-018820.txt   9618711

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT atra-20230331_lab.xml EX-101.LAB 541396
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT atra-20230331_def.xml EX-101.DEF 188354
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT atra-20230331_cal.xml EX-101.CAL 72274
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT atra-20230331_pre.xml EX-101.PRE 381804
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT atra-20230331.xsd EX-101.SCH 77591
66 EXTRACTED XBRL INSTANCE DOCUMENT atra-20230331_htm.xml XML 1655535
Mailing Address 2380 CONEJO SPECTRUM ST SUITE 200 THOUSAND OAKS CA 91320
Business Address 2380 CONEJO SPECTRUM ST SUITE 200 THOUSAND OAKS CA 91320 805-623-4244
Atara Biotherapeutics, Inc. (Filer) CIK: 0001604464 (see all company filings)

IRS No.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36548 | Film No.: 23897912
SIC: 2836 Biological Products, (No Diagnostic Substances)